ImmunityBio, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.

Symbol
IBRX on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
23 Feb 2026

Latest SEC snapshot (2026-02-19) highlights Return On Equity 71.0%, Return On Assets -36.2%, and Operating Margin -169.0%.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

50.8/100

Caution Confidence high

Return On Equity

71%

Metric score 100.0/100

Return On Assets

-36%

Metric score 0.0/100

Financial Health

Current Ratio
5.1x
Quick Ratio
4.62x
Debt to Equity
-1.79x

Strengths

Return On Equity, Revenues YoY, and NetIncomeLoss YoY

Watchpoints

Return On Assets, Operating Margin, and Current Ratio

Key metrics snapshot

Return On Equity

71%

YoY: -7.6%

Industry median: -47% (n=217)

View history

Return On Assets

-36%

YoY: -15%

Industry median: -45% (n=216)

View history

Operating Margin

-169%

YoY: -90%

Industry median: -314% (n=94)

View history

Current Ratio

5.1x

YoY: +52%

Industry median: 3.67x (n=218)

View history

Quick Ratio

4.62x

YoY: -20%

Industry median: 2.63x (n=83)

View history

Debt-to-equity

-1.79x

YoY: +11%

Industry median: 0.28x (n=202)

View history

Revenues YoY

668%

YoY:

Industry median: 17% (n=40)

View history

NetIncomeLoss YoY

15%

YoY:

Industry median: -9.9% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity 71% -7.6%
Return On Assets -36% -15%
Operating Margin -169% -90%

Financial Health

Metric Latest value YoY change
Current Ratio 5.1x +52%
Quick Ratio 4.62x -20%
Debt-to-equity -1.79x +11%

Growth

Metric Latest value YoY change
Revenues YoY 668%
NetIncomeLoss YoY 15%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 1,028,111,456 +20%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%